Peps
What is Bremelanotide?
Bremelanotide is a prescription melanocortin agonist studied for a defined form of low sexual desire associated with distress. It is also known as PT-141.
Biological role or research focus
Melanocortin signaling and sexual desire.
Its defined clinical use should not be generalized to erectile dysfunction or sexual performance.
Role reference: MedlinePlus · Bremelanotide ↗
Names you may encounter
PT-141 · PT141 · Vyleesi
Search terms can include brands, combinations, or historical names. They are not automatic product equivalents.
- Class / identity
- Melanocortin receptor agonist
- Main research area
- Sexual desire and related distress
- Evidence featured
- Human randomized trial
- Source check
- October 4, 2026
Source: MedlinePlus · Bremelanotide ↗
Molecular structure
Mechanism & research rationale
It activates melanocortin pathways in the nervous system. The relevant clinical question is whether desire and associated distress improve, not whether it changes a reproductive-hormone blood test.
Source: MedlinePlus · Bremelanotide ↗
Clinical uses & product context
The cited medication reference describes acquired low desire in premenopausal women when another condition, relationship issue, or drug does not explain it. This is not a general sexual-performance or male erectile-dysfunction indication.
Source: MedlinePlus · Bremelanotide ↗
What does the evidence show?
Selected published evidence, with the population, findings, and limits kept together. These original summaries draw on publication abstracts; they are not a systematic review.
Human randomized trial · 2019
RECONNECT
Bremelanotide for the Treatment of Hypoactive Sexual Desire Disorder: Two Randomized Phase 3 Trials.
- Population / model
- 1,267 premenopausal women randomized across two studies of hypoactive sexual desire disorder.
- Study design
- Two double-blind 24-week studies comparing bremelanotide with placebo.
- Main finding
- Desire scores improved and distress scores decreased more with treatment. Nausea, flushing, and headache were more frequent.
- Limits & context
- The endpoints were validated symptom scales. These results do not establish treatment for every cause of low desire, male erectile dysfunction, or general sexual performance.
Read the original paper for methods, adverse events, funding, and conflicts of interest. Publisher access may require a subscription.
Further reading · 4 additional publication links
Exact-name PubMed search checked 2026-10-04. These records have not been appraised. A name match can include related compounds, combinations, or other formulations; it does not establish safety or benefit.
Bremelanotide. ↗
· 2012 · Review
Bremelanotide. ↗
· 2006 · Review
Hypoactive Sexual Desire Disorder in Women: Physiology, Assessment, Diagnosis, and Treatment. ↗
Journal of midwifery & women's health · 2021 Nov · Journal Article, Review
Read available full text ↗
Bremelanotide: First Approval. ↗
Drugs · 2019 Sep · Journal Article, Review
New editorial updates
New source discoveries
Links appear automatically. Unreviewed discoveries are not verified medical findings.
Safety & precautions
Key precautions
Nausea and flushing are common. Uncontrolled hypertension or heart disease are important exclusions. Skin darkening may persist, and effects on oral-medication absorption warrant attention.
Source: MedlinePlus · Bremelanotide ↗
This is not a complete list of contraindications, interactions, or adverse effects. Medicine labels apply to specific products and indications; research-use listings are not interchangeable with approved medicines.
What are people discussing?
No editorial transcript note has been reviewed for this profile yet. Below are the matching video records available for exploration; title and caption matches are not verified claims.
Watch the source discussions
3 matching video records · 1 with captions indexed.
Across the full library, 30 caption files are indexed from 20,199 inventoried videos. Most transcripts remain unreviewed. Select a thumbnail or timestamp to watch inside PepsRadar. Thumbnail images load from YouTube.
Mind Pump Show
Hormones, Peptides & Body Transformation with Phil Vella CEO of Vita Bella Health | Mind Pump 2882 ↗
Captions indexed · Automatic matches need review
Biohackingturkey
Bremelanotid Peptid Hakkında 5 Kritik Gerçek! (PT-141) ↗
Title match · Captions not indexed
Biohackingturkey
PT-141 Peptidi Nedir? Libido Artırıcı Hormonun Sırrı ↗
Title match · Captions not indexed
Sources & supplier listings
Listings are grouped by the vendor’s stated identity. Blends and modified derivatives are labeled separately. Inclusion is not a quality assessment or an endorsement.
PT-141 (10 mg)
American Peptides · Vendor-labeled research use only
$60.00
Listed in stock · Snapshot 2026-10-05
Options may vary. Shipping and tax excluded.
Affiliate link · PepsRadar may earn a commission from purchases through this link. Affiliate disclosure.
PT-141 (10 mg)
PSPeptides · Vendor-labeled research use only
$44.99
Listed in stock · Snapshot 2026-10-05
Options may vary. Shipping and tax excluded.
Affiliate link · PepsRadar may earn a commission from purchases through this link. Affiliate disclosure.
Catalog checked 2026-10-04. Seller listings retain their stated intended use. Shops covered: BioLongevity Labs, BioLongevity Supplements, American Peptides, PSPeptides. This is not a market-wide comparison. Affiliate participation does not determine evidence or editorial coverage.
Questions worth asking
- Which indication and formulation does the source describe?
- Does the video make a broader claim than the source supports?
- Its defined clinical use should not be generalized to erectile dysfunction or sexual performance.
- What adverse effects, uncertainty, and conflicts of interest does the original source report?
Frequently asked questions
Is PT-141 another name for bremelanotide?
Yes, it is a commonly used development name. The identity of an actual product still needs verification.
Source: MedlinePlus · Bremelanotide ↗
Did RECONNECT measure fertility?
No. Its primary outcomes concerned sexual desire and distress, not ovulation, pregnancy, or live birth.
References & editorial record
- MedlinePlus · Bremelanotide ↗
- Bremelanotide for the Treatment of Hypoactive Sexual Desire Disorder: Two Randomized Phase 3 Trials. ↗
Source notes checked 2026-10-04. Original PepsRadar summaries. Not reviewed by a medical professional. Topic grouping is editorial navigation, not a treatment recommendation. Video notes specify which excerpts were reviewed; no full transcripts are published.
PUT THE EVIDENCE IN CONTEXT
Research guides
RESEARCH FIELD GUIDE
Melanotan I vs Melanotan II: one became a medicine, one did not
Melanotan I and Melanotan II were developed in the same lab to darken skin, but only Melanotan I (afamelanotide) became an approved medicine, for a rare light-sensitivity disease. Melanotan II has only tiny early studies and documented safety concerns.
Read the guide →